Rossari Biotech Limited Stock Current Liabilities

ROSSARI Stock   796.95  3.50  0.44%   
Rossari Biotech Limited fundamentals help investors to digest information that contributes to Rossari Biotech's financial success or failures. It also enables traders to predict the movement of Rossari Stock. The fundamental analysis module provides a way to measure Rossari Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rossari Biotech stock.
The current Total Current Liabilities is estimated to decrease to about 2.2 B. The current Non Current Liabilities Total is estimated to decrease to about 568.9 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Rossari Biotech Limited Company Current Liabilities Analysis

Rossari Biotech's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Current Liabilities

 = 

Payables

+

Accrued Debt

More About Current Liabilities | All Equity Analysis
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition

Rossari Total Current Liabilities

Total Current Liabilities

2.23 Billion

As of now, Rossari Biotech's Total Current Liabilities is increasing as compared to previous years.
In accordance with the recently published financial statements, Rossari Biotech Limited has a Current Liabilities of 0.0. This is 100.0% lower than that of the Chemicals sector and 100.0% lower than that of the Materials industry. The current liabilities for all India stocks is 100.0% higher than that of the company.

Did you try this?

Run Stock Tickers Now

   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

Rossari Fundamentals

About Rossari Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Rossari Biotech Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rossari Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rossari Biotech Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Rossari Stock

Rossari Biotech financial ratios help investors to determine whether Rossari Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rossari with respect to the benefits of owning Rossari Biotech security.